Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
134,608,103
-
Total 13F shares
-
98,595,824
-
Share change
-
+232,084
-
Total reported value
-
$845,901,469
-
Put/Call ratio
-
38%
-
Price per share
-
$8.58
-
Number of holders
-
116
-
Value change
-
+$2,628,498
-
Number of buys
-
55
-
Number of sells
-
58
Institutional Holders of Tango Therapeutics, Inc. - Common Stock (TNGX) as of Q2 2024
As of 30 Jun 2024,
Tango Therapeutics, Inc. - Common Stock (TNGX) was held by
116 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,595,824 shares.
The largest 10 holders included
TRV GP IV, LLC, EcoR1 Capital, LLC, FMR LLC, Boxer Capital, LLC, Nextech Invest Ltd., Southpoint Capital Advisors LP, T. Rowe Price Investment Management, Inc., BlackRock Inc., VANGUARD GROUP INC, and Bain Capital Life Sciences Investors, LLC.
This page lists
116
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.